APA

Toledo H., Baly A., Castro O., Resik S., Laferté J., Rolo F., Navea L., Lobaina L., Cruz O., Míguez J., Serrano T., Sierra B., Pérez L., Ricardo M. E., Dubed M., Lubián A. L., Blanco M., Millán J. C., Ortega A., Iglesias E., Pentón E., Martín Z., Pérez J., Díaz M. & Duarte C. A. (20010927). A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. : Vaccine.

Chicago

Toledo H, Baly A, Castro O, Resik S, Laferté J, Rolo F, Navea L, Lobaina L, Cruz O, Míguez J, Serrano T, Sierra B, Pérez L, Ricardo M E, Dubed M, Lubián A L, Blanco M, Millán J C, Ortega A, Iglesias E, Pentón E, Martín Z, Pérez J, Díaz M and Duarte C A. 20010927. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. : Vaccine.

Harvard

Toledo H., Baly A., Castro O., Resik S., Laferté J., Rolo F., Navea L., Lobaina L., Cruz O., Míguez J., Serrano T., Sierra B., Pérez L., Ricardo M. E., Dubed M., Lubián A. L., Blanco M., Millán J. C., Ortega A., Iglesias E., Pentón E., Martín Z., Pérez J., Díaz M. and Duarte C. A. (20010927). A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. : Vaccine.

MLA

Toledo H, Baly A, Castro O, Resik S, Laferté J, Rolo F, Navea L, Lobaina L, Cruz O, Míguez J, Serrano T, Sierra B, Pérez L, Ricardo M E, Dubed M, Lubián A L, Blanco M, Millán J C, Ortega A, Iglesias E, Pentón E, Martín Z, Pérez J, Díaz M and Duarte C A. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. : Vaccine. 20010927.